Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival

Cancer

Volumn 117, Issue 8, 2011, Pages 1711-1720

  Zakrzewski, Jan ^a   Geraghty, Laurel N ^a   Rose, Amy E ^a   Christos, Paul J ^b   Mazumdar, Madhu ^b   Polsky, David ^a   Shapiro, Richard ^a   Berman, Russell ^a   Darvishian, Farbod ^a   Hernando, Eva ^a   Pavlick, Anna ^a   Osman, Iman ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

brain; melanoma; metastases; outcomes; survival; ulceration

Indexed keywords

ANTINEOPLASTIC AGENT; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CRANIOTOMY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS INDEX; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOSURGERY; RISK FACTOR; ULCER;

AGE FACTORS; AGED; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79953785848     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25643     Document Type: Article

References (28)

1. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF., Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998; 88: 11-20. (Pubitemid 28018958)
2. Fife KM, Colman MH, Stevens GN, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004; 22: 1293-1300. (Pubitemid 41079844)
3. Meier S, Baumert BG, Maier T, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie. 2004; 27: 145-149. (Pubitemid 38621604)
4. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745-751. (Pubitemid 27181303)
5. Thompson JF, Morton D, Kroon B., Textbook of Melanoma. Vol 1. London: Martin Dunitz; 2004.
6. Cruz-Munoz W, Man S, Xu P, Kerbel RS., Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res. 2008; 68: 4500-4505.
7. Raizer JJ, Hwu WJ, Panageas KS, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol. 2008; 10: 199-207.
8. Hofmann MA, Coll SH, Kuchler I, et al. Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women? Dermatology. 2007; 215: 10-16.
9. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27: 6199-6206.
10. Gimotty PA, Elder DE, Fraker DL, et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol. 2007; 25: 1129-1134. (Pubitemid 46596766)
11. Eggermont AM,. Ulceration of primary melanoma and responsiveness to adjuvant interferon therapy: analysis of the adjuvant trials EORTC18952 and EORTC18991 in 2644 patients [abstract]. J Clin Oncol. 2009; 27 (15 suppl):462s. Abstract 9007.
12. Baurain J,. Association of primary melanoma ulceration and clinical benefit of adjuvant vaccination with tumor-specific antigen peptides [abstract]. J Clin Oncol. 2009; 27 (15 suppl):134s. Abstract 3022.
13. Wich LG, Hamilton HK, Shapiro RL, et al. Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res. 2009; 1: 35-43.
14. Vihinen P, Koskivuo I, Syrjanen K, Tervahartiala T, Sorsa T, Pyrhonen S., Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma. Melanoma Res. 2008; 18: 268-273.
15. Grande Sarpa H, Reinke K, Shaikh L, et al. Prognostic significance of extent of ulceration in primary cutaneous melanoma. Am J Surg Pathol. 2006; 30: 1396-1400. (Pubitemid 44655473)
16. Soong SJ, Shaw HM, Balch CM, McCarthy WH, Urist MM, Lee JY., Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg. 1992; 16: 191-195.
17. Bos PD, Zhang XH, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009; 459: 1005-1009.
18. Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI., Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma. 2005; 52: 150-158.
19. Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM., Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer. 1984; 53: 2550-2552.
20. Majer M, Jensen RL, Shrieve DC, et al. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer. 2007; 110: 1329-1337. (Pubitemid 47435606)
21. Mathieu D, Kondziolka D, Cooper PB, et al. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery. 2007; 60: 471-481; discussion 481-482.
22. Boasberg PD, O'Day SJ, Kristedja TS, et al. Biochemotherapy for metastatic melanoma with limited central nervous system involvement. Oncology. 2003; 64: 328-335. (Pubitemid 36682944)
23. Coit D, Andtbacka R, Bichakjian C, et al. Melanoma. J Natl Compr Canc Netw. 2009; 7: 250-275.
24. Yancovitz M, Finelt N, Warycha MA, et al. Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma. Cancer. 2007; 110: 1107-1114. (Pubitemid 47312877)
25. Buzaid AC, Sandler AB, Mani S, et al. Role of computed tomography in the staging of primary melanoma. J Clin Oncol. 1993; 11: 638-643. (Pubitemid 23105671)
26. Brenner DJ, Hall EJ., Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007; 357: 2277-2284. (Pubitemid 350190758)
27. Kienast Y, von Baumgarten L, Fuhrmann M, et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2010; 16: 116-122.
28. Xiong Z, Gharagozlou S, Vengco I, Chen W, Ohlfest JR., Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis. Clin Cancer Res. 2008; 14: 5484-5493.